Insider · CIK 0001579587

Marken James G.

Reports to the SEC for 1 company · BAUDETTE, MN

sec.gov

Transactions

Companies

Filings

CIK

0001579587

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-07	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP OPS & PROD DEV	MExercise/Conversion	+7,250 sh	$49.51	+$359K	123,616
2024-06-07	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP OPS & PROD DEV	MExercise/Conversion	+5,300 sh	$57.06	+$302K	128,916
2024-06-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−11.1K sh	$67.70	−$751K	117,829
2024-06-07	ANIPANI PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	SVP OPS & PROD DEV	MExercise/Conversion	−7,250 sh	$49.51	−$359K	0
2024-06-07	ANIPANI PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	SVP OPS & PROD DEV	MExercise/Conversion	−5,300 sh	$57.06	−$302K	0
2024-04-10	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−2,799 sh	$66.96	−$187K	116,006
2024-03-23	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−3,653 sh	$69.58	−$254K	118,805
2024-03-07	ANIPANI PHARMACEUTICALS INCS Sale	SVP OPS & PROD DEV	SSale	−24.3K sh	$66.37	−$1.62M	124,492
2024-03-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−2,034 sh	$66.71	−$136K	122,458
2024-02-29	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−1,058 sh	$67.67	−$71.6K	148,830
2024-02-14	ANIPANI PHARMACEUTICALS INCA Award	SVP OPS & PROD DEV	AAward	+10.1K sh	—	—	143,178
2024-02-14	ANIPANI PHARMACEUTICALS INCA Award	SVP OPS & PROD DEV	AAward	+6,710 sh	—	—	149,888
2023-08-23	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP OPS & PROD DEV	MExercise/Conversion	+3,750 sh	$40.59	+$152K	135,377
2023-08-23	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP OPS & PROD DEV	MExercise/Conversion	+1,667 sh	$33.00	+$55K	137,044
2023-08-23	ANIPANI PHARMACEUTICALS INCS Sale	SVP OPS & PROD DEV	SSale	−3,932 sh	$63.00	−$248K	133,112
2023-08-23	ANIPANI PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	SVP OPS & PROD DEV	MExercise/Conversion	−3,750 sh	$40.59	−$152K	0
2023-08-23	ANIPANI PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	SVP OPS & PROD DEV	MExercise/Conversion	−1,667 sh	$33.00	−$55K	0
2023-04-10	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−2,289 sh	$38.50	−$88.1K	131,627
2023-03-28	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−524 sh	$38.62	−$20.2K	112,206
2023-03-23	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−2,452 sh	$37.82	−$92.7K	112,730
2023-03-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−1,951 sh	$44.23	−$86.3K	115,691
2023-03-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−509 sh	$44.23	−$22.5K	115,182
2023-02-28	ANIPANI PHARMACEUTICALS INCA Award	SVP OPS & PROD DEV	AAward	+13K sh	—	—	125,232
2023-02-28	ANIPANI PHARMACEUTICALS INCA Award	SVP OPS & PROD DEV	AAward	+8,684 sh	—	—	133,916
2022-08-15	ANIPANI PHARMACEUTICALS INCS Sale	SVP OPS & PROD DEV	SSale	−5,172 sh	$37.79	−$195K	117,642
2022-08-12	ANIPANI PHARMACEUTICALS INCS Sale	SVP OPS & PROD DEV	SSale	−12.9K sh	$37.04	−$478K	122,814
2022-04-27	ANIPANI PHARMACEUTICALS INCA Award	SVP OPS & PROD DEV	AAward	+6,644 sh	—	—	135,708
2022-04-10	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−1,878 sh	$29.91	−$56.2K	129,064
2022-04-06	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−337 sh	$29.69	−$10K	130,942
2022-03-28	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−524 sh	$28.17	−$14.8K	131,279
2022-03-24	ANIPANI PHARMACEUTICALS INCA Award	SVP OPS & PROD DEV	AAward	+19.9K sh	—	—	131,803
2022-03-23	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−2,452 sh	$27.03	−$66.3K	111,869
2021-04-12	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−1,878 sh	$31.86	−$59.8K	114,321
2021-04-06	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−337 sh	$33.69	−$11.4K	116,199
2021-03-31	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−278 sh	$36.14	−$10K	116,536
2021-03-29	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−524 sh	$32.68	−$17.1K	116,814
2021-03-23	ANIPANI PHARMACEUTICALS INCA Award	SVP OPS & PROD DEV	AAward	+32K sh	—	—	117,338
2020-04-10	ANIPANI PHARMACEUTICALS INCA Award	SVP OPS & PROD DEV	AAward	+24.5K sh	—	—	85,297
2020-04-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−144 sh	$43.93	−$6,325.92	60,749
2020-04-06	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−337 sh	$43.22	−$14.6K	60,893
2019-05-17	ANIPANI PHARMACEUTICALS INCS Sale	SVP OPS & PROD DEV	SSale	−8,907 sh	$70.67	−$629K	61,230
2019-05-14	ANIPANI PHARMACEUTICALS INCS Sale	SVP OPS & PROD DEV	SSale	−4,917 sh	$70.31	−$346K	70,137
2019-04-16	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−115 sh	$68.60	−$7,889	75,054
2019-04-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−144 sh	$70.50	−$10.2K	75,169
2019-04-06	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−337 sh	$70.50	−$23.8K	75,313
2019-03-31	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−278 sh	$70.54	−$19.6K	75,650
2019-03-28	ANIPANI PHARMACEUTICALS INCA Award	SVP OPS & PROD DEV	AAward	+6,848 sh	—	—	75,928
2019-03-28	ANIPANI PHARMACEUTICALS INC · Stock OptionsA Award	SVP OPS & PROD DEV	AAward	+8,285 sh	—	—	8,285
2018-05-22	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−253 sh	$61.88	−$15.7K	69,080
2018-04-16	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP OPS & PROD DEV	FTax Payment	−115 sh	$60.21	−$6,924.15	69,333

Recent filings

Accepted (ET)
Jun 114
Marken James G.0001579587-24-000013
SEC(opens sec.gov)
Apr 114
Marken James G.0001579587-24-000011
SEC(opens sec.gov)
Mar 254
Marken James G.0001579587-24-000009
SEC(opens sec.gov)
Mar 74
Marken James G.0001579587-24-000006
SEC(opens sec.gov)
Mar 14
Marken James G.0001579587-24-000004
SEC(opens sec.gov)
Feb 164
Marken James G.0001579587-24-000002
SEC(opens sec.gov)
Aug 254
Marken James G.0001579587-23-000005
SEC(opens sec.gov)
Apr 124
Marken James G.0001104659-23-044634
SEC(opens sec.gov)
Apr 44
Marken James G.0001104659-23-041737
SEC(opens sec.gov)

Companies

ANI PHARMACEUTICALS INCSVP OPS & PROD DEVANIP

Address

C/O BIOSANTE PHARMACEUTICALS, INC. 210 MAIN STREET W.

BAUDETTE, MN, 56623